Status: retired, Primitive. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3299353018 | Transdermal form hyoscine hydrobromide (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3299778016 | Transdermal form hyoscine hydrobromide | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488661013 | Product containing scopolamine hydrobromide in transdermal dosage form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3497808019 | Scopolamine hydrobromide in transdermal dosage form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3497809010 | Product containing scopolamine hydrobromide in transdermal dosage form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Scopolamine hydrobromide in transdermal dosage form | Is a | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Scopolamine hydrobromide in transdermal dosage form | Is a | Scopolamine in topical dosage form | false | Inferred relationship | Some | ||
| Scopolamine hydrobromide in transdermal dosage form | Has active ingredient | Hyoscine hydrobromide | false | Inferred relationship | Some | ||
| Scopolamine hydrobromide in transdermal dosage form | Has manufactured dose form | Prolonged-release transdermal drug delivery system | false | Inferred relationship | Some | ||
| Scopolamine hydrobromide in transdermal dosage form | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR